Drug Resistance and Novel Therapies in Cancers

n/a

Bibliographic Details
Main Author: Zhixiang Wang
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
n/a
Online Access:https://www.mdpi.com/2072-6694/12/10/2929
id doaj-b983b03f6a2342f2bff139ee6d191e1e
record_format Article
spelling doaj-b983b03f6a2342f2bff139ee6d191e1e2020-11-25T02:44:51ZengMDPI AGCancers2072-66942020-10-01122929292910.3390/cancers12102929Drug Resistance and Novel Therapies in CancersZhixiang Wang0Signal Transduction Research Group, Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canadan/ahttps://www.mdpi.com/2072-6694/12/10/2929n/a
collection DOAJ
language English
format Article
sources DOAJ
author Zhixiang Wang
spellingShingle Zhixiang Wang
Drug Resistance and Novel Therapies in Cancers
Cancers
n/a
author_facet Zhixiang Wang
author_sort Zhixiang Wang
title Drug Resistance and Novel Therapies in Cancers
title_short Drug Resistance and Novel Therapies in Cancers
title_full Drug Resistance and Novel Therapies in Cancers
title_fullStr Drug Resistance and Novel Therapies in Cancers
title_full_unstemmed Drug Resistance and Novel Therapies in Cancers
title_sort drug resistance and novel therapies in cancers
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-10-01
description n/a
topic n/a
url https://www.mdpi.com/2072-6694/12/10/2929
work_keys_str_mv AT zhixiangwang drugresistanceandnoveltherapiesincancers
_version_ 1724765672230092800